Real-time enrollment status for this malignancy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT04991922 |
| Recruiting Status | Recruiting |
| Condition | Malignancy |
| Phase | Clinical Trial |
| Target Enrollment | 100,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | BostonGene |
| Last Updated on CT.gov | February 7, 2024 (Feb 7, 2024) |
As of July 13, 2026: Clinical trial NCT04991922 is currently recruiting participants. This clinical trial study for malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by BostonGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04991922 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04991922 was last updated Feb 7, 2024 (February 7, 2024). HelloStudys verifies this status automatically.